1. Fu, Dragony, Jordan, Jennifer J, Samson, Leona D. 2013. Human ALKBH7 is required for alkylation and oxidation-induced programmed necrosis. In Genes & development, 27, 1089-100. doi:10.1101/gad.215533.113. https://pubmed.ncbi.nlm.nih.gov/23666923/
2. Chen, Kaijie, Shen, Dongjie, Tan, Lin, Lu, Changlian, Gu, Xuefeng. 2022. A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7. In Frontiers in genetics, 13, 822261. doi:10.3389/fgene.2022.822261. https://pubmed.ncbi.nlm.nih.gov/35222541/
3. Wang, Tianyu, Lin, Bojian, Cai, Boyu, Peng, Hu, Liu, Huanhai. 2024. Integrative pan-cancer analysis reveals the prognostic and immunotherapeutic value of ALKBH7 in HNSC. In Aging, 16, 12781-12805. doi:10.18632/aging.205981. https://pubmed.ncbi.nlm.nih.gov/39400540/
4. Bjørnstad, Linn G, Meza, Trine J, Otterlei, Marit, Meza-Zepeda, Leonardo A, Falnes, Pål Ø. 2012. Human ALKBH4 interacts with proteins associated with transcription. In PloS one, 7, e49045. doi:10.1371/journal.pone.0049045. https://pubmed.ncbi.nlm.nih.gov/23145062/